Linked Life Data

20150181

Source:http://linkedlifedata.com/resource/pubmed/id/20150181

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-3-15
pubmed:abstractText
Rationale Linezolid may be effective for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB); however, serious adverse events are common and there is little information on the management of these toxicities.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1460-2091
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
775-83
pubmed:meshHeading
pubmed-meshheading:20150181-Acetamides, pubmed-meshheading:20150181-Adult, pubmed-meshheading:20150181-Aged, pubmed-meshheading:20150181-Antitubercular Agents, pubmed-meshheading:20150181-Bone Marrow Diseases, pubmed-meshheading:20150181-Child, pubmed-meshheading:20150181-Female, pubmed-meshheading:20150181-Gastrointestinal Diseases, pubmed-meshheading:20150181-Humans, pubmed-meshheading:20150181-Incidence, pubmed-meshheading:20150181-Male, pubmed-meshheading:20150181-Middle Aged, pubmed-meshheading:20150181-Nervous System Diseases, pubmed-meshheading:20150181-New York City, pubmed-meshheading:20150181-Oxazolidinones, pubmed-meshheading:20150181-Retrospective Studies, pubmed-meshheading:20150181-Treatment Outcome, pubmed-meshheading:20150181-Tuberculosis, Multidrug-Resistant, pubmed-meshheading:20150181-Young Adult
pubmed:year
2010
pubmed:articleTitle
Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
pubmed:affiliation
New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control, 225 Broadway, 22nd floor, New York, NY 10007, USA. hanger@health.nyc.gov
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't